Citalopram HBr (Citalopram Hydrobromide) Patent Expiration, LOE Window & CMS Spending

Citalopram HBr (Citalopram Hydrobromide) by Torrent Pharmac: Off-Patent Genericized (AB Competition), 8 AB generics, $70.7M 2024 CMS Part D & Medicaid spend, and $1,911 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorTorrent Pharmac
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors8
2024 CMS Total Public Spend$70.7M
2024 Medicare Part D Spend$48.6M
2024 Medicaid Spend$22.1M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,911 intro WAC)